e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Post-transplant complications: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A case series of fidaxomicin for treatment of Clostridium difficile infection (CDI) in lung transplant (LTx) recipients
T. Welte (Hannover, Germany)
Source:
International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session:
Post-transplant complications: from pathogenesis to treatment
Session type:
Poster Discussion
Number:
3312
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Welte (Hannover, Germany). A case series of fidaxomicin for treatment of Clostridium difficile infection (CDI) in lung transplant (LTx) recipients. Eur Respir J 2014; 44: Suppl. 58, 3312
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Nocardia infections in lung transplant recipients (LxTR)
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
First reported case of disseminated
talaromyces marneffei
infection in a lung transplant patient
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Nocardia infections after lung transplantation: A case series
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcome
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Severe infection due to
corynebacterium striatum
or
amycolatum
in 6 lung transplanted patients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Carbapenem-resistant Klebsiella pneumoniae in lung transplant recipients: A case series
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
Non-tuberculous mycobacterium infection in lung transplant recipients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Infectious complications after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193
Year: 2003
Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Azole plasma concentrations in lung transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Oral human serum immunoglobulin for norovirus diarrhea in pulmonary transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Fungal infections in transplant recipients
Source: Eur Respir J 2001; 17: 133-140
Year: 2001
Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching
Source: Eur Respir J 2005; 26: Suppl. 49, 636s
Year: 2005
Cytomegalovirus as predisposing agent to respiratory infections in heart transplant patients
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Fungal re-colonization in cystic fibrosis or bronchiectasis patients after lung transplantation: Incidence, time of onset and related-factors
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Respiratory syncytial viral infections in lung transplant recipients: Treatment with aerolised ribavirin
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Early and late viral infections after lung transplantation
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Aspergillus
infections in lung transplant recipients. Risk factors and outcome
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept